Hemorrhage Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Browse Cochrane Pediatric Emergency Medicine Reviews
Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
- Visit
Crowther CA, Crosby DD, Henderson-Smart DJ
Crowther CA, Crosby DD, Henderson-Smart DJ
OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.
OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.
Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury
Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury
- Visit
Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators
Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators
OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.
OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.
Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
- Visit
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
Cochrane Systematic Review: Vitamin K prior to preterm birth for preventing neonatal periventricular haemorrhage
- Visit
Crowther CA, Crosby DD, Henderson-Smart DJ
Crowther CA, Crosby DD, Henderson-Smart DJ
OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.
OBJECTIVES: The objective of this review was to assess the effects of vitamin K administered to women at risk of imminent very preterm birth to prevent periventricular haemorrhage and associated neurological injury in the infant.
Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury
Cochrane Systematic Review: Antifibrinolytic drugs for acute traumatic injury
- Visit
Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators
Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators
OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.
OBJECTIVES: To quantify the effects of antifibrinolytic drugs on mortality, vascular occlusive events, surgical intervention and receipt of blood transfusion after acute traumatic injury.
Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
Cochrane Systematic Review: Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia
- Visit
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
Simpson E, Lin Y, Stanworth S, Birchall J, Doree C, Hyde C
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
OBJECTIVES: To assess the effectiveness of rFVIIa when used therapeutically to control active bleeding or prophylactically to prevent (excessive) bleeding in patients without haemophilia.
